Sleep Aids (Pharmacies) - Indonesia

Revenue in the Sleep Aids market is projected to reach US$71.27m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 8.22%, resulting in a market volume of US$105.80m by 2029.
In global comparison, most revenue will be generated United States (US$1.47bn in 2024).
In relation to total population figures, per person revenues of US$0.25 are generated in 2024.

Definition:
The Sleep Aids market encompasses a diverse array of over-the-counter (OTC) medications and supplements designed to aid individuals in managing sleep-related disorders, including insomnia, sporadic sleep disruptions, and jetlag resulting from adjusting to different time zones. This market includes products containing ingredients such as Doxylamine Succinate, Diphenhydramine, Melatonin, and herbal remedies. Notable sleep aid products include Natrol Melatonin, Vitafusion, Alteril, Unisom SleepTabs, and Kalms. This market exclusively covers product sales through pharmacies.

Additional information:
The Sleep Aids market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Single Active Ingredient Formulations
Combination Active Ingredient Formulations
Herbal Remedies
Melatonin Products

Prescription Sleep Medications
Products for Chronic Insomnia which are not designed to address only occasional sleep challenges

The Sleep Aids (Pharmacies) market in Indonesia has been experiencing steady growth in recent years.

Customer preferences: Customers in Indonesia are increasingly seeking sleep aids to combat sleep disorders and improve the quality of their sleep. This trend can be attributed to various factors, including the growing awareness about the importance of sleep for overall health and well-being. Additionally, the increasing prevalence of stress and anxiety in modern lifestyles has also contributed to the rising demand for sleep aids.

Trends in the market: One of the key trends in the Sleep Aids (Pharmacies) market in Indonesia is the growing popularity of natural and herbal sleep aids. Customers are increasingly opting for products that are perceived as safer and have fewer side effects. This trend is in line with the global shift towards natural and organic products in the health and wellness industry. As a result, manufacturers are introducing a wide range of herbal sleep aids to cater to this growing demand. Another trend in the market is the increasing availability of sleep aids in pharmacies. Pharmacies are becoming the preferred distribution channel for sleep aids, as they offer convenience and accessibility to customers. Pharmacies also provide a trusted source of information and advice on sleep aids, which is particularly important for customers who may be seeking professional guidance.

Local special circumstances: Indonesia is a country with a large population and a growing middle class. As disposable incomes rise, more people are able to afford sleep aids, leading to an increase in demand. Additionally, the fast-paced lifestyle and high-stress levels in urban areas of Indonesia have contributed to the growing prevalence of sleep disorders, further driving the demand for sleep aids.

Underlying macroeconomic factors: The growing economy of Indonesia has played a significant role in the development of the Sleep Aids (Pharmacies) market. As the country's GDP continues to increase, consumers have more purchasing power, which has led to a greater demand for sleep aids. Furthermore, the government's focus on healthcare and wellness has also contributed to the growth of the market, with initiatives aimed at promoting healthy lifestyles and raising awareness about sleep disorders. In conclusion, the Sleep Aids (Pharmacies) market in Indonesia is experiencing growth due to increasing customer preferences for sleep aids, the availability of natural and herbal products, the popularity of pharmacies as distribution channels, the local special circumstances of a large population and growing middle class, and the underlying macroeconomic factors of a growing economy and government initiatives.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.